Could a painkiller help treat alcoholism? scientists investigate
NCT ID NCT06029296
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a single dose of diclofenac, a common pain reliever, can change a specific brain chemical in people with alcohol use disorder. Twelve adults with mild to severe alcohol use disorder will receive either diclofenac or a placebo in a double-blind fashion. The goal is to see if diclofenac increases kynurenic acid levels, which may help understand how the brain works in addiction. This is an early-stage study focused on learning, not treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALCOHOL USE DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Maryland Psychiatric Research Center (MPRC) Treatment Research Program (TRP)
Catonsville, Maryland, 21228, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a brain zapping headset curb relapse in addiction?
- Can a smartphone app tame Alcohol-Related liver disease?
- Calm in a room: can sensory therapy soothe the mind?
- Can a brief alcohol intervention improve mental health treatment?
- Smartphone support for sobriety: a trial tests digital tools in black communities
- Emergency room could be the starting point for alcohol addiction treatment